PL2701716T3 - Hydrolizaty białkowe jako środki do przezwyciężania uzależnień - Google Patents

Hydrolizaty białkowe jako środki do przezwyciężania uzależnień

Info

Publication number
PL2701716T3
PL2701716T3 PL12717282T PL12717282T PL2701716T3 PL 2701716 T3 PL2701716 T3 PL 2701716T3 PL 12717282 T PL12717282 T PL 12717282T PL 12717282 T PL12717282 T PL 12717282T PL 2701716 T3 PL2701716 T3 PL 2701716T3
Authority
PL
Poland
Prior art keywords
agents
protein hydrolysates
addiction
overcoming
overcoming addiction
Prior art date
Application number
PL12717282T
Other languages
English (en)
Inventor
Guillen Santiago Eusebio Fernandez-Reumann
Regina Goralczyk
Joris Kloek
Marijn Christoffel Waander Kroes
Hasan Mohajeri
Van Guido Alexander Wingen
Jonas Wittwer
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL2701716T3 publication Critical patent/PL2701716T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/189Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Business, Economics & Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Physics & Mathematics (AREA)
  • Educational Administration (AREA)
  • Educational Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
PL12717282T 2011-04-28 2012-04-26 Hydrolizaty białkowe jako środki do przezwyciężania uzależnień PL2701716T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11164063 2011-04-28
EP12717282.3A EP2701716B1 (en) 2011-04-28 2012-04-26 Protein hydrolysates as agents for overcoming addiction
PCT/EP2012/057638 WO2012146651A1 (en) 2011-04-28 2012-04-26 Protein hydrolysates as agents for overcoming addiction

Publications (1)

Publication Number Publication Date
PL2701716T3 true PL2701716T3 (pl) 2018-02-28

Family

ID=44263161

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12717282T PL2701716T3 (pl) 2011-04-28 2012-04-26 Hydrolizaty białkowe jako środki do przezwyciężania uzależnień

Country Status (5)

Country Link
US (2) US20140050715A1 (pl)
EP (1) EP2701716B1 (pl)
ES (1) ES2651638T3 (pl)
PL (1) PL2701716T3 (pl)
WO (1) WO2012146651A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2382910T3 (es) 2006-11-02 2012-06-14 Dsm Ip Assets B.V. Uso de hidrolizados de lisozima que contienen triptófano
PL2701716T3 (pl) 2011-04-28 2018-02-28 Dsm Ip Assets B.V. Hydrolizaty białkowe jako środki do przezwyciężania uzależnień
EP2615470A1 (en) * 2012-01-12 2013-07-17 Koninklijke Philips Electronics N.V. MR imaging with B1 mapping
NL2022627B1 (en) * 2019-02-22 2020-08-31 Newtricious Bv Lysozyme hydrolysate for proactive inhibitory control and for attention
EP4033149A1 (en) 2021-01-22 2022-07-27 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Monitoring combustible matter in a gaseous stream

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796853B1 (ko) 2000-12-06 2008-01-22 캄피나 쥐벨 베.붸. 과량 트립토판 함유 펩티드의 제조방법
WO2004069265A1 (en) 2003-02-07 2004-08-19 Campina B.V. Use of tryptophan rich peptides
US7064104B2 (en) 2003-06-13 2006-06-20 The Procter & Gamble Company Methods of managing the symptoms of premenstrual syndrome
US20050089546A1 (en) 2003-09-16 2005-04-28 Dick Wurtman Compositions and methods comprising complex carbohydrate and alpha-lactalbumin
GB0326477D0 (en) 2003-11-13 2003-12-17 Shs Int Ltd Medicaments for use in promoting and maintaining abstinence
CN1968691B (zh) 2004-04-19 2010-12-29 麒麟麦酒株式会社 用于通过葡糖异生作用加速酒精代谢或从疲劳恢复的组合物
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
CN101535494B (zh) 2006-11-02 2014-04-09 帝斯曼知识产权资产管理有限公司 含有色氨酸的肽
ES2382910T3 (es) 2006-11-02 2012-06-14 Dsm Ip Assets B.V. Uso de hidrolizados de lisozima que contienen triptófano
CN102076222B (zh) 2008-04-29 2014-04-09 帝斯曼知识产权资产管理有限公司 包含碳水化合物和含色氨酸的肽的组合物
KR101698216B1 (ko) 2008-04-29 2017-01-19 디에스엠 아이피 어셋츠 비.브이. 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물
CN103153326B (zh) 2010-10-05 2015-08-19 帝斯曼知识产权资产管理有限公司 含有色氨酸的肽
PL2701716T3 (pl) 2011-04-28 2018-02-28 Dsm Ip Assets B.V. Hydrolizaty białkowe jako środki do przezwyciężania uzależnień
CN104334037B (zh) * 2012-11-02 2019-02-22 帝斯曼知识产权资产管理有限公司 富含色氨酸的蛋白水解产物的用途

Also Published As

Publication number Publication date
EP2701716A1 (en) 2014-03-05
US20140050715A1 (en) 2014-02-20
US20170087226A1 (en) 2017-03-30
EP2701716B1 (en) 2017-11-01
ES2651638T3 (es) 2018-01-29
WO2012146651A1 (en) 2012-11-01
US10668133B2 (en) 2020-06-02

Similar Documents

Publication Publication Date Title
IL227514A (en) Rebaudioside – Mugroside mixture v
GB201103955D0 (en) Antibodies
GB201107849D0 (en) Cooperative positioning
GB201112056D0 (en) Antibodies
ZA201308255B (en) Albumin variants
IL232743A0 (en) anticancer fusion protein
PL2474441T3 (pl) Podstawka samochodowa
IL228438A0 (en) New methods for protein purification
GB201113811D0 (en) Protein recovery
EP2765920A4 (en) CUFF CONNECTORS
PL2699674T3 (pl) Syntetyczne warianty fitazy
GB201111183D0 (en) Peptide
SG10201606218WA (en) Purified Proteins
GB201115910D0 (en) Peptides
PL2701716T3 (pl) Hydrolizaty białkowe jako środki do przezwyciężania uzależnień
GB201107468D0 (en) Protein expression systems
ZA201307011B (en) Engine
HUP1200319A2 (en) Starter
EP2714074A4 (en) ANTIBODIES AGAINST EMR1
IL232029A0 (en) Mirror
GB2496056B (en) Surround Trim
GB201101794D0 (en) Protein production
GB201113089D0 (en) Protein hydrolysates
GB201103169D0 (en) Protein expression
HUP1100282A2 (en) Protein factor